These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21266233

  • 21. Lineage-specific transcription factor aberrations in AML.
    Mueller BU, Pabst T.
    Cancer Treat Res; 2010; 145():109-25. PubMed ID: 20306248
    [Abstract] [Full Text] [Related]

  • 22. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
    Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H, German-Austrian Acute Myeloid Leukemia Study Group.
    N Engl J Med; 2008 May 01; 358(18):1909-18. PubMed ID: 18450602
    [Abstract] [Full Text] [Related]

  • 23. Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.
    Benthaus T, Schneider F, Mellert G, Zellmeier E, Schneider S, Kakadia PM, Hiddemann W, Bohlander SK, Feuring-Buske M, Braess J, Spiekermann K, Dufour A.
    Br J Haematol; 2008 Oct 01; 143(2):230-9. PubMed ID: 18752591
    [Abstract] [Full Text] [Related]

  • 24. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
    Liang H, Samanta S, Nagarajan L.
    Oncogene; 2005 Apr 14; 24(16):2625-34. PubMed ID: 15782145
    [Abstract] [Full Text] [Related]

  • 25. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997 Apr 14; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A, Bica MG, Cascio L, Floridia PM, Mineo AM, Russo M, Fabbiano F, Santoro A.
    Am J Hematol; 2010 May 14; 85(5):331-9. PubMed ID: 20425795
    [Abstract] [Full Text] [Related]

  • 28. CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16).
    Helbling D, Mueller BU, Timchenko NA, Schardt J, Eyer M, Betts DR, Jotterand M, Meyer-Monard S, Fey MF, Pabst T.
    Blood; 2005 Aug 15; 106(4):1369-75. PubMed ID: 15855281
    [Abstract] [Full Text] [Related]

  • 29. Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients.
    Musialik E, Bujko M, Kober P, Grygorowicz MA, Libura M, Przestrzelska M, Juszczyński P, Borg K, Florek I, Jakóbczyk M, Baranowska A, Siedlecki JA.
    Leuk Res; 2014 Jul 15; 38(7):850-6. PubMed ID: 24878001
    [Abstract] [Full Text] [Related]

  • 30. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA, Humbert M, Valk PJ, Behre G, Leibundgut EO, Torbett BE, Fey MF, Tschan MP.
    Br J Haematol; 2013 Mar 15; 160(6):855-9. PubMed ID: 23252456
    [No Abstract] [Full Text] [Related]

  • 31. The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.
    Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S, Lister A, Rowley JD, Huegli B, Fey MF, Pabst T.
    Proc Natl Acad Sci U S A; 2004 Sep 07; 101(36):13312-7. PubMed ID: 15326310
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
    Du M, Wang M, Liu M, Fu S, Lin Y, Huo Y, Yu J, Yu X, Wang C, Xiao H, Wang L.
    J Exp Clin Cancer Res; 2024 Mar 13; 43(1):79. PubMed ID: 38475919
    [Abstract] [Full Text] [Related]

  • 34. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
    Seipel K, Marques MT, Bozzini MA, Meinken C, Mueller BU, Pabst T.
    Clin Cancer Res; 2016 Feb 01; 22(3):746-56. PubMed ID: 26408402
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.
    Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI.
    Leuk Res; 2014 May 01; 38(5):625-31. PubMed ID: 24703161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.